METYROSINE

METYROSINE was reported 81 times

METYROSINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CATECHOLAMINE CRISIS 2 0.0541
1 PHAEOCHROMOCYTOMA MALIGNANT 1 0.0385
2 PARAGANGLION NEOPLASM MALIGNANT 1 0.0333
3 FEMORAL ARTERY EMBOLISM 1 0.0169
4 PARAGANGLION NEOPLASM 2 0.0137
5 REPERFUSION INJURY 1 0.0072
6 BLOOD PRESSURE ORTHOSTATIC 1 0.0063
7 PHAEOCHROMOCYTOMA 4 0.0061
8 PHAEOCHROMOCYTOMA CRISIS 1 0.0047
9 EMPHYSEMATOUS CYSTITIS 1 0.0047
10 XERODERMA 1 0.0037
11 ENTEROCOLITIS BACTERIAL 1 0.0036
12 PULMONARY VASCULAR DISORDER 1 0.0021
13 MEASLES 1 0.0019
14 CRYSTALLURIA 1 0.0018
15 RENAL ISCHAEMIA 1 0.0018
16 ADRENAL HAEMORRHAGE 1 0.0018
17 URINARY TRACT INFECTION PSEUDOMONAL 1 0.0017
18 INTESTINAL PSEUDO-OBSTRUCTION 1 0.0011
19 ONCOLOGIC COMPLICATION 1 0.0010
20 ADMINISTRATION SITE EXTRAVASATION 1 0.0010
21 BLADDER NEOPLASM 1 0.0006
22 VASCULAR PSEUDOANEURYSM 1 0.0006
23 EXTREMITY NECROSIS 1 0.0006
24 RENAL HAEMORRHAGE 1 0.0005
25 PULMONARY ALVEOLAR HAEMORRHAGE 2 0.0004
26 DEPRESSIVE SYMPTOM 1 0.0003
27 CARDIAC DYSFUNCTION 1 0.0003
28 INABILITY TO AFFORD MEDICATION 2 0.0002
29 TRISMUS 1 0.0002
30 STRESS CARDIOMYOPATHY 1 0.0002
31 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
32 MOUTH HAEMORRHAGE 1 0.0001
33 BOWEL MOVEMENT IRREGULARITY 1 0.0001
34 HAEMORRHAGIC STROKE 1 0.0001
35 PYELONEPHRITIS 1 0.0001
36 LEUKAEMIA 1 0.0001
37 PARKINSONISM 1 0.0001
38 PSYCHOTIC DISORDER 3 0.0001
39 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
40 HYPERTENSIVE CRISIS 1 0.0001
41 NEOPLASM 1 0.0001
42 DELIRIUM 3 0.0001
43 HYPOXIA 3 0.0001
44 SCHIZOPHRENIA 1 0.0001
45 ILEUS 1 0.0001
46 SINUS TACHYCARDIA 1 0.0001
47 GASTROENTERITIS 1 0.0001
48 INSURANCE ISSUE 1 0.0001
49 DEVICE RELATED INFECTION 1 0.0001
50 HYPOGLYCAEMIA 3 0.0001
51 BLOOD POTASSIUM INCREASED 1 0.0001
52 SOMNOLENCE 12 0.0001
53 PARANOIA 1 0.0001
54 ORTHOSTATIC HYPOTENSION 1 0.0001
55 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
56 TREATMENT NONCOMPLIANCE 3 0.0001
57 BLOOD GLUCOSE ABNORMAL 1 0.0001
58 AGRANULOCYTOSIS 1 0.0001
59 GASTRIC ULCER 1 0.0001
60 DYSTONIA 1 0.0001
61 BLOOD PRESSURE ABNORMAL 1 0.0001
62 BODY TEMPERATURE INCREASED 1 0.0000
63 MENTAL DISORDER 2 0.0000
64 SNEEZING 1 0.0000
65 PRODUCT AVAILABILITY ISSUE 1 0.0000
66 BLOOD GLUCOSE DECREASED 2 0.0000
67 DIABETIC KETOACIDOSIS 1 0.0000
68 PNEUMONIA ASPIRATION 1 0.0000
69 HAEMOPTYSIS 1 0.0000
70 RENAL IMPAIRMENT 3 0.0000
71 HYPERSOMNIA 1 0.0000
72 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
73 ACUTE MYOCARDIAL INFARCTION 1 0.0000
74 HOSPITALISATION 5 0.0000
75 STAPHYLOCOCCAL INFECTION 1 0.0000
76 BLOOD PRESSURE DECREASED 2 0.0000
77 URINARY RETENTION 1 0.0000
78 NEOPLASM MALIGNANT 2 0.0000
79 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
80 ANGER 1 0.0000
81 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
82 HYPERKALAEMIA 1 0.0000
83 THERAPY INTERRUPTED 2 0.0000
84 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
85 DYSKINESIA 1 0.0000
86 NEUTROPHIL COUNT DECREASED 1 0.0000
87 CARDIO-RESPIRATORY ARREST 1 0.0000
88 PULMONARY OEDEMA 1 0.0000
89 THERAPY NON-RESPONDER 1 0.0000
90 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
91 ADVERSE EVENT 2 0.0000
92 HYPOKALAEMIA 1 0.0000
93 PNEUMONIA 7 0.0000
94 INFECTION 3 0.0000
95 DRUG INTOLERANCE 2 0.0000
96 BLOOD PRESSURE INCREASED 3 0.0000
97 SPEECH DISORDER 1 0.0000
98 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
99 OFF LABEL USE 16 0.0000
100 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
101 SEPSIS 2 0.0000
102 NECK PAIN 1 0.0000
103 PANCYTOPENIA 1 0.0000
104 HYPONATRAEMIA 1 0.0000
105 PYREXIA 6 0.0000
106 BONE PAIN 1 0.0000
107 THERAPEUTIC RESPONSE DECREASED 1 0.0000
108 STOMATITIS 1 0.0000
109 PLEURAL EFFUSION 1 0.0000
110 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
111 AMNESIA 1 0.0000
112 HYPOTENSION 3 0.0000
113 HEPATIC ENZYME INCREASED 1 0.0000
114 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
115 CONSTIPATION 3 0.0000
116 RESPIRATORY FAILURE 1 0.0000
117 AGITATION 1 0.0000
118 DIABETES MELLITUS 1 0.0000
119 INJECTION SITE SWELLING 1 0.0000
120 CARDIAC FAILURE 1 0.0000
121 CARDIAC FAILURE CONGESTIVE 1 0.0000
122 CARDIAC ARREST 1 0.0000
123 CEREBROVASCULAR ACCIDENT 2 0.0000
124 MALAISE 5 0.0000
125 INSOMNIA 3 0.0000
126 TACHYCARDIA 1 0.0000
127 ADVERSE DRUG REACTION 1 0.0000
128 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2 0.0000
129 DYSPHAGIA 1 0.0000
130 PULMONARY EMBOLISM 1 0.0000
131 ATRIAL FIBRILLATION 1 0.0000
132 SINUSITIS 1 0.0000
133 HAEMOGLOBIN DECREASED 1 0.0000
134 PLATELET COUNT DECREASED 1 0.0000
135 DIARRHOEA 6 0.0000
136 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
137 INCORRECT DOSE ADMINISTERED 2 0.0000
138 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
139 DECREASED APPETITE 2 0.0000
140 PALPITATIONS 1 0.0000
141 VOMITING 4 0.0000
142 DISEASE PROGRESSION 1 0.0000
143 LOSS OF CONSCIOUSNESS 1 0.0000
144 NEUTROPENIA 1 0.0000
145 WEIGHT DECREASED 2 0.0000
146 ANXIETY 2 0.0000
147 PRODUCT DOSE OMISSION ISSUE 2 0.0000
148 CONDITION AGGRAVATED 2 0.0000
149 TREMOR 1 0.0000
150 DIZZINESS 3 0.0000
151 URTICARIA 1 0.0000
152 TOXICITY TO VARIOUS AGENTS 1 0.0000
153 URINARY TRACT INFECTION 1 0.0000
154 NO ADVERSE EVENT 1 0.0000
155 NASOPHARYNGITIS 1 0.0000
156 ANAEMIA 1 0.0000
157 ALOPECIA 1 0.0000
158 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
159 ABDOMINAL PAIN UPPER 1 0.0000
160 HYPERTENSION 1 0.0000
161 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
162 FATIGUE 3 0.0000
163 DRUG INEFFECTIVE 5 0.0000
164 COUGH 1 0.0000
165 DYSPNOEA 2 0.0000
166 DEATH 3 0.0000
167 PAIN IN EXTREMITY 1 0.0000
168 FALL 1 0.0000
169 ASTHENIA 1 0.0000
170 PRURITUS 1 0.0000
171 NAUSEA 2 0.0000
172 ARTHRALGIA 1 0.0000
173 PAIN 1 0.0000
174 HEADACHE 1 0.0000